Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial (vol 29, pg 1437, 2023)
Catherine J. Mummery,Anne Borjesson-Hanson,Daniel J. Blackburn,Everard G. B. Vijverberg,Peter Paul De Deyn,Simon Ducharme,Michael Jonsson,Anja Schneider,Juha O. Rinne,Albert C. Ludolph, Ralf Bodenschatz,Holly Kordasiewicz,Eric E. Swayze,Bethany Fitzsimmons,Laurence Mignon,Katrina M. Moore,Chris Yun,Tiffany Baumann,Dan Li,Daniel A. Norris,Rebecca Crean,Danielle L. Graham,Ellen Huang,Elena Ratti,C. Frank Bennett,Candice Junge,Roger M. Lane NATURE MEDICINE（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper